Phase I trial investigating the tolerability, pharmacodynamics and pharmacokinetics of escalating single doses of S-mecamylamine in healthy volunteers

Trial Profile

Phase I trial investigating the tolerability, pharmacodynamics and pharmacokinetics of escalating single doses of S-mecamylamine in healthy volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 18 Mar 2008

At a glance

  • Drugs Dexmecamylamine (Primary)
  • Indications Depressive disorders
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Targacept
  • Most Recent Events

    • 18 Mar 2008 Status change from planning to recruiting, as reported by a Targacapt media release.
    • 01 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top